Supplier profile
NOVO NORDISK PHARMA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 27 Apr 2009 to 24 Sept 2026.
Awards won
183
all time
Attributed value
€77.5m
68 shared, unvalued
Buyers
103
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Servicio de Salud de las Illes Balears | 12 | €1.5m |
| Dirección General de Planificación Económica | 6 | €1.9m |
| Osakidetza | 6 | €2.7m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 6 | €8.4m |
| Servicio Murciano de Salud | 5 | not attributable |
| CORPORACIO DE SALUT DEL MARESME I LA SELVA | 4 | not attributable |
| Dirección del Instituto Nacional de Gestión Sanitaria (INGESA) | 4 | €1k |
| Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau | 4 | €101k |
| Gerencia de Atención Integrada de Cuenca | 4 | €1.0m |
| Gerencia de Atención Integrada de Puertollano | 4 | €896k |
What they win
Awards
Showing 26–50 of 183 awards we hold
- Suministro, respetuoso con el medio ambiente, de medicamentos de Factor VIII de coagulación recombinante, para varias comunidades autónomas y centros de Instituto Nacional de Gestión Sanitaria (INGESA) en Ceuta y Melilla ↗Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)€695awarded 12 Mar 2025
- Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 2- REFACTO ↗Servicio de Salud de las Illes Balears€368kawarded 17 Feb 2025
- Sum medicamentos exclusivos Abbvie; Bayer; Boehringer; Glaxosmithkline; Novo Nordisk; Pzifer; Servier; Takeda y Viiv, GAI Cuenca. ↗Gerencia de Atención Integrada de Cuenca€23kawarded 10 Feb 2025
- Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 07- AFSTYLA ↗Servicio de Salud de las Illes Balears€175kawarded 6 Nov 2024
- Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Suministro, respetuoso con el medio ambiente, de medicamentos de factor VIII de coagulación recombinante con destino al Servicio de Farmacia del Complejo Asistencial Universitario de León (Derivado AM INGESA 2021/063) ↗Gerencia de Atención Especializada de Leónshared awardawarded 3 Sept 2024
- Suministro, respetuoso con el medio ambiente, de medicamentos de factor VIII de coagulación recombinante con destino al Servicio de Farmacia del Complejo Asistencial Universitario de León (Derivado AM INGESA 2021/063) ↗Gerencia de Atención Especializada de León€202kawarded 2 Sept 2024
- Suministro del suministro de los principios activos denominados "Novoseven (Eptacog Alfa Activado) 2 MG (100 KUI) Inyectable IV"Y "Novoseven (Eptacog Alfa Activado) 5 MG (250 KUI) Inyectable IV". ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€71kawarded 8 Aug 2024
- Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2023 0001153871) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.shared awardawarded 8 Aug 2024
- Spain – Pharmaceutical products – Suministro de Eptacog Alfa Activado(DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€351kawarded 4 Jul 2024
- Contrato basado A.M. Suministro de medicamentos Factor VIII ↗Gerencia de Atención Integrada de Puertollano€170kawarded 17 May 2024
- Spain – Pharmaceutical products – Suministros ( CCA. 6AX64H-) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaénshared awardawarded 1 May 2024
- Suministro de medicamentos exclusivos para los centros sanitarios dependientes del Servei de Salut de les Illes Balears ↗Servicio de Salud de las Illes Balearsshared awardawarded 26 Jan 2024
- Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 10- ESPEROCT ↗Servicio de Salud de las Illes Balears€340kawarded 12 Dec 2023
- Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 04- NOVOEIGHT ↗Servicio de Salud de las Illes Balears€35kawarded 12 Dec 2023
- Spain-Oviedo: Various medicinal products ↗SERVICIO DE SALUD DEL PRINCIPADO DE ASTURIAS€813kawarded 28 Nov 2023
- Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 10 ESPEROCT ↗Servicio de Salud de las Illes Balears€40kawarded 8 Nov 2023
- Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 10 ESPEROCT ↗Servicio de Salud de las Illes Balears€40kawarded 8 Nov 2023
- Procedimiento derivado del AM 2021/063 DE INGESA para la adquisición del medicamentos de Factor VIII LOTE 10 - ESPEROCT ↗Servicio de Salud de las Illes Balears€26kawarded 26 Oct 2023
- Medicamentos_suministro medicamento exclusivo Eptacog Alfa ↗Servicio de Salud - Servicios Centrales€813kawarded 24 Oct 2023
- Spain-Terrassa: Recording systems and exploration devices ↗Consorci Sanitari de Terrassashared awardawarded 23 Oct 2023
- Spain-Calella: Pharmaceutical products ↗CORPORACIO DE SALUT DEL MARESME I LA SELVAshared awardawarded 29 Sept 2023
- Spain-Murcia: Pharmaceutical products ↗SERVICIO MURCIANO DE SALUDshared awardawarded 26 Sept 2023
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€1.5mawarded 26 Sept 2023
- Spain-Madrid: Pharmaceutical products ↗SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE€234kawarded 19 Sept 2023
- Spain-Tortosa: Pharmaceutical products ↗GESTIO SANITARIA I ASSISTENCIAL DE TORTOSA, S.A.M.shared awardawarded 12 Sept 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.